These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6790155)

  • 1. Management of inflammatory carcinoma of breast with combined modality approach - an update.
    Buzdar AU; Montague ED; Barker JL; Hortobagyi GN; Blumenschein GR
    Cancer; 1981 Jun; 47(11):2537-42. PubMed ID: 6790155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
    Krutchik AN; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Gutterman JU; Yap HY; Hersh EM
    J Surg Oncol; 1979; 11(4):325-32. PubMed ID: 109703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal treatment for inflammatory breast cancer.
    Thoms WW; McNeese MD; Fletcher GH; Buzdar AU; Singletary SE; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):739-45. PubMed ID: 2487034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
    Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving local control for inflammatory carcinoma of the breast.
    Sener SF; Imperato JP; Khandekar JD; Ragin A; Beck J; Merkel DE
    Surg Gynecol Obstet; 1992 Aug; 175(2):141-4. PubMed ID: 1636139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
    Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
    Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
    Ueno NT; Buzdar AU; Singletary SE; Ames FC; McNeese MD; Holmes FA; Theriault RL; Strom EA; Wasaff BJ; Asmar L; Frye D; Hortobagyi GN
    Cancer Chemother Pharmacol; 1997; 40(4):321-9. PubMed ID: 9225950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
    Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
    J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy.
    Barker JL; Montague ED; Peters LJ
    Cancer; 1980 Feb; 45(4):625-9. PubMed ID: 6766788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
    Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
    Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal treatment of locoregionally advanced breast cancer.
    Hortobagyi GN; Blumenschein GR; Spanos W; Montague ED; Buzdar AU; Yap HY; Schell F
    Cancer; 1983 Mar; 51(5):763-8. PubMed ID: 6687377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory carcinoma of the breast: treatment results on 107 patients.
    Fields JN; Perez CA; Kuske RR; Fineberg BB; Bartlett N
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):249-55. PubMed ID: 2753755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
    Buzdar AU; Blumenschein GR; Gutterman JU; Tashima CK; Hortobagyi GN; Smith TL; Campos LT; Wheeler WL; Hersh EM; Freireich EJ; Gehan EA
    JAMA; 1979 Oct; 242(14):1509-13. PubMed ID: 470088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy.
    Wiseman C; Jessup JM; Smith TL; Hersh E; Bowen J; Blumenshein G
    Cancer; 1982 Mar; 49(6):1266-71. PubMed ID: 6800632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer.
    Buzdar AU; Smith TL; Powell KC; Blumenschein GR; Gehan EA
    Breast Cancer Res Treat; 1982; 2(2):163-9. PubMed ID: 6897369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
    Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
    Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Vilcoq JR; Bataini JP; Calle R; Fenton J; Mathieu G; Rousseau J; Asselain B
    Bull Cancer; 1981; 68(2):171-86. PubMed ID: 7016224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive combined modality therapy for advanced local-regional breast carcinoma.
    Loprinzi CL; Carbone PP; Tormey DC; Rosenbaum PR; Caldwell W; Kline JC; Steeves RA; Ramirez G
    J Clin Oncol; 1984 Mar; 2(3):157-63. PubMed ID: 6230422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory breast carcinoma. Effective multimodal approach.
    Burton GV; Cox EB; Leight GS; Prosnitz LR; Iglehart JD; Olsen GA; Seigler HF; Hart LL
    Arch Surg; 1987 Nov; 122(11):1329-32. PubMed ID: 3675196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.